- Home
- RBOT
as 05-30-2025 4:00pm EST
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 33.9M | IPO Year: | N/A |
| Target Price: | $9.25 | AVG Volume (30 days): | 13.0K |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -10.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.27 - $19.00 | Next Earning Date: | 05-12-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Vicarious Surgical Inc. News
RBOT Breaking Stock News: Dive into RBOT Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
GuruFocus.com
19 days ago
Vicarious Surgical Inc (RBOT) Q1 2025 Earnings Call Highlights: Strategic Partnerships and ...
Business Wire
19 days ago
Vicarious Surgical Reports First Quarter 2025 Financial Results
Business Wire
19 days ago
Vicarious Surgical Announces New Collaboration with UMass Memorial Medical Center
Business Wire
a month ago
Vicarious Surgical to Report First Quarter 2025 Financial Results on May 12, 2025
Business Wire
2 months ago
Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE
Business Wire
2 months ago
Vicarious Surgical Announces President Transition to Board Member Role
Zacks
2 months ago
What Makes D8 (RBOT) a New Buy Stock
Compare RBOT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RBOT Vicarious Surgical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.